Request for Covid-19 Impact Assessment of this Report
Market Segmentation:
By Type (Assays, Devices, Consumables), Disease Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), Deployment (Automated, Manual), End User (Hospitals, Clinics, Diagnostic Laboratories, Academic Institutes, Others), Distribution Channel (Direct, Indirect), Country (Saudi Arabia, South Africa, Egypt, U.A.E., Israel and Rest of Middle East & Africa)
Some of the major factors contributing to the growth of the market are:
• Growing government initiative regarding diabetic diseases
• Rising awareness among the people
Market Players:
The key market players for Middle East and Africa diabetic assays market are listed below:
• Abbott
• Danaher
• Merck KGaA
• SIEMENS HEALTHINEERS AG
• Bio-Rad Laboratories, Inc.
• DiaSorin S.p.A.
• EKF Diagnostics
• DRG INSTRUMENTS GMBH
• PTS Diagnostics
• Ortho Clinical Diagnostics
• Medipan GmbH
• Diagnostic Automation/Cortez Diagnostics Inc.
• Diazyme Laboratories, Inc.
• Ethos Biosciences, Inc.
• BioAssay Systems
• Tosoh Corporation
• Abnova Corporation
• Monobind Inc
• ORGENTEC Diagnostika GmbH
• ALPCO
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.10 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING PREVALENCE OF DIABETES
3.1.2 INCREASING GERIATRIC POPULATION
3.1.3 TECHNOLOGICAL ADVANCEMENT
3.1.4 AVAILABILITY OF REIMBURSEMENT
3.1.5 INCREASING DEMAND FOR THE HAND-HELD DIAGNOSTIC DEVICES
3.2 RESTRAINT
3.2.1 PRODUCT RECALL
3.2.2 HIGH COST OF THE ASSAY
3.2.3 IMPLEMENTATION OF EXCISE DUTY BY THE U.S. GOVERNMENT
3.3 OPPORTUNITIES
3.3.1 RISING GOVERNMENT INITIATIVES
3.3.2 STRATEGIC INITIATIVE BY MARKET PLAYERS
3.3.3 RISE IN AWARENESS AMONG THE POPULATION
3.3.4 GROWING HEALTHCARE INFRASTRUCTURE
3.4 CHALLENGES
3.4.1 STRINGENT REGULATION
3.4.2 LACK OF SKILLED PROFESSIONALS
3.4.3 LOW PENETRATION IN DEVELOPING ECONOMIES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 REGULATORY PROCEDURE
7 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY TYPE
7.1 OVERVIEW
7.2 ASSAYS
7.2.1 DIABETES DIAGNOSTICS GLUCOSE ASSAY
7.2.2 DIABETES DIAGNOSTICS HBA1C ASSAY
7.3 DEVICES
7.3.1 ANALYZERS
7.3.2 SOFTWARE
7.4 CONSUMABLES
7.4.1 TEST STRIPS
7.4.2 REAGENT
7.4.3 OTHERS
8 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DISEASE TYPE
8.1 OVERVIEW
8.2 TYPE 2 DIABETES
8.3 TYPE 1 DIABETES
8.4 GESTATIONAL DIABETES
9 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DEPLOYMENT
9.1 OVERVIEW
9.2 AUTOMATED
9.3 MANUAL
10 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 DIAGNOSTIC LABORATORIES
10.4 CLINICS
10.5 ACADEMIC INSTITUTES
10.6 OTHERS
11 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT
11.3 INDIRECT
12 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY GEOGRAPHY
12.1 MIDDLE EAST & AFRICA
12.1.1 SAUDI ARABIA
12.1.2 SOUTH AFRICA
12.1.3 EGYPT
12.1.4 U.A.E.
12.1.5 ISRAEL
12.1.6 REST OF MIDDLE EAST & AFRICA
13 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
14 COMPANY PROFILE
14.1 BIO-RAD LABORATORIES, INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENT
14.2 ABBOTT
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENT
14.3 SIEMENS HEALTHINEERS AG
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENT
14.4 DANAHER
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.5 DIASORIN S.P.A.
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENT
14.6 ABNOVA CORPORATION
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 ALPCO
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 BIOASSAY SYSTEMS
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENT
14.9 DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.10 DIAZYME LABORATORIES, INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 DRG INSTRUMENTS GMBH
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 EKF DIAGNOSTICS HOLDINGS PLC
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENT
14.13 ETHOS BIOSCIENCES, INC.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 MEDIPAN GMBH
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 MERCK KGAA
14.15.1 COMPANY SNAPSHOT
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPMENT
14.16 MONOBIND INC.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 ORGENTEC DIAGNOSTIKA GMBH
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENT
14.18 ORTHO CLINICAL DIAGNOSTICS
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENT
14.19 PTS DIAGNOSTICS (A SUBSIDIARY OF SANNUO BIOSENSOR CO., LTD.)
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.20 TOSOH CORPORATION
14.20.1 COMPANY SNAPSHOT
14.20.2 REVENUE ANALYSIS
14.20.3 PRODUCT PORTFOLIO
14.20.4 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
TABLE 1 CANADA REIMBURSEMENT LIMITS FOR TEST STRIPS FOR EACH 365-DAY PERIOD
TABLE 2 IRELAND REIMBURSEMENT FOR TEST STRIPS
TABLE 3 COMPARISON OF NGSP-CERTIFIED A1C POC DEVICES
TABLE 4 MEDICAL DEVICE RECALLS
TABLE 5 BIO-RAD LABORATORIES, INC. (U.S.) DIABETIC ASSAYS PRICES
TABLE 6 PRIVATE-SECTOR R&D INVESTMENT IN MEDICAL DEVICES AND EQUIPMENT ( IN USD MILLION)
TABLE 7 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
TABLE 8 DIRECT COSTS OF DIABETES (IN USD)
TABLE 9 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA ASSAYS DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA DEVICES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA TYPE 2 DIABETES DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA TYPE 1 DIABETES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA GESTATIONAL DIABETES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA AUTOMATED IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA MANUAL IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA HOSPITALS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA DIAGNOSTIC LABORATORIES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA CLINICS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA ACADEMIC INSTITUTES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA OTHERS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA DIRECT IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA INDIRECT IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 41 SAUDI ARABIA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 42 SAUDI ARABIA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 43 SAUDI ARABIA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 44 SAUDI ARABIA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 45 SAUDI ARABIA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 46 SAUDI ARABIA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 47 SAUDI ARABIA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 48 SAUDI ARABIA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 49 SOUTH AFRICA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 50 SOUTH AFRICA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 51 SOUTH AFRICA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 52 SOUTH AFRICA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 53 SOUTH AFRICA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 54 SOUTH AFRICA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 55 SOUTH AFRICA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 56 SOUTH AFRICA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 57 EGYPT DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 58 EGYPT DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 59 EGYPT ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 60 EGYPT CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 61 EGYPT DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 62 EGYPT DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 63 EGYPT DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 64 EGYPT DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 65 U.A.E. DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 66 U.A.E. DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 67 U.A.E. ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 68 U.A.E. CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 69 U.A.E. DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 70 U.A.E. DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 71 U.A.E. DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 72 U.A.E. DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 73 ISRAEL DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 74 ISRAEL DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 75 ISRAEL ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 76 ISRAEL CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 77 ISRAEL DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 78 ISRAEL DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 79 ISRAEL DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 80 ISRAEL DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 81 REST OF MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...